Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries

BACKGROUND AND OBJECTIVES: COVID‐19 convalescent plasma (CCP) has been used, predominantly in high‐income countries (HICs) to treat COVID‐19; available data suggest the safety and efficacy of use. We sought to develop guidance for procurement and use of CCP, particularly in low‐ and middle‐income co...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Vox Sang
Main Authors: Bloch, Evan M., Goel, Ruchika, Wendel, Silvano, Burnouf, Thierry, Al‐Riyami, Arwa Z., Ang, Ai Leen, DeAngelis, Vincenzo, Dumont, Larry J., Land, Kevin, Lee, Cheuk‐kwong, Oreh, Adaeze, Patidar, Gopal, Spitalnik, Steven L., Vermeulen, Marion, Hindawi, Salwa, Van den Berg, Karin, Tiberghien, Pierre, Vrielink, Hans, Young, Pampee, Devine, Dana, So – Osman, Cynthia
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2020
נושאים:
Original Papers
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7323328/
https://ncbi.nlm.nih.gov/pubmed/32533868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vox.12970
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים